29 /100
MEDIUM RISK
Score updated May 30, 2026

PACK — Ranpak Holdings Corp. Dilution Risk Tracker

Track PACK dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track PACK — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
0
📊 Float Risk
55
⚠️ Warrant Exposure
70
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
29%
📜 Warrant Exercise 50%
• Massive warrant overhang: 33% of shares outstanding
• Elevated warrant risk score (70/100)
📉 Score Deterioration 15%
• Score climbed 5 points (worsening)
🔔 Track PACK — Get forecast alerts →

💹 Market Data

Market Cap$590.26M
Shares Outstanding85.54M
Float47.36M
Cash$50.90M
Debt$429.70M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 0.6% shares (2025Q4 vs prior)
120 institutional holders · 78.77M shares
#1 JS Capital Management LLC 30.53M shares
#2 SOROS CAPITAL MANAGEMENT LLC 4.63M shares
#3 G2 Investment Partners Management LLC 3.34M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest2.68M
Days to Cover2.8
% of Float5.7%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
4 INSIDER TRANSACTION Apr 07, 2026
4 INSIDER TRANSACTION Apr 07, 2026
4 INSIDER TRANSACTION Apr 07, 2026
4 INSIDER TRANSACTION Mar 12, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track PACK Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking PACK — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for PACK
📊 PACK FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 PACK Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.